January 16, 2026
Risks to valuations already in process, leaves the C> sector vulnerable to further disappointment
Some running for flights to end the hectic JPM HC week
Pre-open Signals: 2 Positive and 2 Negative; If you understand probabilities, the inevitable is easier to maneuver
Never leave retail investor uninformed … I say what others won’t, so you can do what others
January 16, 2026
Financing on Deck: Harvard Apparatus RT (OTCQB: HRGN (Notice of Exempt Offering of Securities); who or what US institution would invest in this “entity”
Broke, no patient data in 4 years, questionable management, serious unpaid bills in hundreds of thousands to partners and employees past and present; even was sued and had to pay for a patient DEATH, usually a death knell foe any company!
WHO and WHAT is its owner ... a Beijing, China percentage (%) “owned”, financed and run company … with patterns of share pricing manipulation? Cash starved, NO clinical data after 5-year ago IND
January 16, 2026
While the healthcare stocks including the C> sector deeply declined
Pre-open Indications: 1 Hit and 3 Miss
Long weekend, as stock and bond markets are closed on Monday for Martin Luther King Jr. Day.
RMi collects, curates, interprets and disseminates cell and gene therapy sector (C>) fact-based news, trustable and verified intel of share pricing data bridging the gap to an investment decision
Never leave a retail investor uninformed! It’s not always time to buy or sell; but it is time to KNOW why!
TGIF
January 16, 2026
Financing on Deck: Harvard Apparatus RT (OTCQB: HRGN (Notice of Exempt Offering of Securities); who or what US institution would invest in this “entity” Closed flat $0.00 Friday after down Thursday +$0.0270) after Wednesday's -$0.10 with 6,980 shares traded after Tuesday’s -$0.38 after Monday’s +$0.01 after Friday’s $0.00) Broke, no patient data in 4 years, questionable management, serious unpaid bills in hundreds of thousands to partners and employees past and present; even was sued and had to pay for a patient DEATH, usually a death knell foe any company! An adjunct, who's providing the lipstick for this pig! WHO and WHAT is its owner ... a Beijing, China percentage (%) “owned”, financed and run company … with patterns of share pricing manipulation? Cash starved, NO clinical data after 5-year ago IND Accumulated deficit to date = $103.2 M in 12 years ... U.S. investors BEWARE, forewarned is forearmed?
January 16, 2026
For all my … <some say> … RANTINGS, I say TRUTH … closed Friday closed up =$o.31 <look at the volume 974,340 shares trading <”someone’s” covering downslide (?) having closed down Tursday -$0.75 or -3.03% with 1.586 M shares traded after Wednesday $0.00 <was as low as -$0.45> afterTuesday +$0.28 <opened -$0.26) after Monday UP +$0.67 after being DOWN on Friday -$1.71 or -6.99% after Thursday's -$0.76 or -2.89% to $25.55 after Wednesday (1/7) was UP +$0.18 ... I believe their I Banks are executing the “PUMP” to protect the offering share pricing after being stripped of value in past sessions. DON’T be distracted – CONTINUE the SELL into strength, right yet again, let's NOT be a set-up for a PONZI schematic? Continuous declines are here soon to stay; timing will be everything until the FDA “speaks;” the higher CAPR rose from 12/2’s $6.36, the steeper the fall! STICKING to my CONVICTION that Capricor Therapeutics (CAPR) is overbought and whose valuation is disconnected from fundamentals.
January 8, 2026
Of $625 M aggregate principal amount of 0.00% convertible senior notes due 2032 and 3,100,776 shares of common stock, at a public offering price of $64.50 per share and pre-funded warrants, at an offering price of $64.499 per pre-funded warrant, for up to 1,550,387 shares of common stock ARWR is up +$1.14 or +1.74% to $66.85 Getting it done while it can and still with a positive response
1 hour 47 min ago
RMi Closing Bell: Fuggily Friday
2 hours ago
RMi Research Note: Harvard Apparatus GT (OTCQB:HRGN): A new financing attempt?
2 hours 3 min ago
RMi Research Note: Capricor Therapeutics (CAPR) DUMP before the next big SLUMP!
10 hours 40 min ago
RMi Pre-opening: A Friday rush or brush-off?
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
